Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk

Summary

This large-scale genomic study, drawing on data from multiple international cohorts including LifeLines and kConFab/AOCS, identified hundreds of genetic variants associated with the timing of menarche through GWAS methodology. The authors investigated whether puberty timing—as indicated by these genetic loci—plays a causal or mediating role in subsequent cancer risk. The work contributes to understanding developmental and reproductive factors in cancer aetiology, though causality remains to be established.

UK applicability

Findings from this international genomic study have potential relevance to UK clinical genetics and public health understanding of cancer risk stratification, though application would require validation in UK populations and integration with existing screening frameworks.

Key measures

Genetic variants (SNPs) associated with age at menarche; associations between menarche timing and cancer risk phenotypes

Outcomes reported

The study identified hundreds of genetic variants associated with age at menarche through genome-wide association analysis. It explored the relationship between puberty timing and subsequent cancer risk as suggested by the findings.

Topic tags